Mesenchymal stem cell therapy for bronchopulmonary dysplasia: current evidence and future directions—a narrative review

Jagriti Jha, Siddhant Passey, Wilbert S. Aronow

Open source

DOI
10.21037/atm-2026-0153
Published
2026-10
Container
Annals of Translational Medicine
Publisher
AME Publishing Company
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.21037/atm-2026-0153,
  title = {Mesenchymal stem cell therapy for bronchopulmonary dysplasia: current evidence and future directions—a narrative review},
  author = {Jagriti Jha and Siddhant Passey and Wilbert S. Aronow},
  year = {2026},
  journal = {Annals of Translational Medicine},
  doi = {10.21037/atm-2026-0153},
  url = {https://doi.org/10.21037/atm-2026-0153}
}

RIS

TY  - JOUR
TI  - Mesenchymal stem cell therapy for bronchopulmonary dysplasia: current evidence and future directions—a narrative review
AU  - Jagriti Jha
AU  - Siddhant Passey
AU  - Wilbert S. Aronow
PY  - 2026
JO  - Annals of Translational Medicine
DO  - 10.21037/atm-2026-0153
UR  - https://doi.org/10.21037/atm-2026-0153
ER  - 

APA

Jha, J., Passey, S., & Aronow, W. S. (2026). Mesenchymal stem cell therapy for bronchopulmonary dysplasia: current evidence and future directions—a narrative review. Annals of Translational Medicine. https://doi.org/10.21037/atm-2026-0153

Source records